NCT06268951

Brief Summary

To determine the characteristics of recovery and symptom relief following ablation of abdominal wall endometriosis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
29mo left

Started May 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
May 2024Dec 2028

First Submitted

Initial submission to the registry

February 13, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

May 9, 2024

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Expected
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

3.7 years

First QC Date

February 13, 2024

Last Update Submit

May 30, 2026

Conditions

Endometriosis

Keywords

Abdominal Wall endometriosis

Outcome Measures

Primary Outcomes (1)

  • Symptom severity due to abdominal wall endometriosis following ablation.

    Using the Endometriosis Health Profile - 30 survey, the impact of ablation on endometriosis-related symptoms will be quantified over time. A numerical rating scale will be used to quantify pain at the site of treated abdominal wall endometriosis.

    Baseline and intermittently over 24 months

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with endometriosis of the abdomen wall.

You may qualify if:

  • Undergoing ablation for abdominal wall endometriosis.

You may not qualify if:

  • Decline to participate in research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Thomas Atwell, M.D.

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 13, 2024

First Posted

February 21, 2024

Study Start

May 9, 2024

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations

US(1)